OR WAIT null SECS
November 15, 2016
Advances in cloud-based IT and user interfaces make it easier to collaborate, but a strong foundation, based on knowledge of data and risk management principles, is needed first.
Are investigations supporting or hindering performance excellence?
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.
In InstantGMP, cloud-based IT and an approach grounded in cGMPs, brings more of the power of paperless recordkeeping to manufacturers, at a fraction of the cost.
Could greater market transparency improve pharmaceutical quality and regulatory compliance?
Ensuring that materials have optimal critical quality attributes for the required formulations is crucial.
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.
November 09, 2016
GS1 US published new guidelines in preparation for the serialization and traceability requirements associated with DSCSA.
November 07, 2016
UPS entered into a definitive purchase agreement to acquire Marken, a provider of supply-chain solutions for the life-science industry.
November 02, 2016
The pharmaceutical industry has weathered its share of “black swan” events.